clinical trial – Adu-Gyasi Dennis

Alternatives to vaccines: what do anti-vaccine people propose?

January 11, 2021 Adu-Gyasi Dennis

One element that has proven to be effective for the control of infectious diseases and found to be mostly under attack is the vaccine. The conspiracy has been enormous and…

TOP STORIES

Google’s top hacker hunter explains why hacking groups get codenames
Google recently changed how it refers and assigns names to hacking groups. TechCrunch spoke with one of the world’s foremost experts on tracking hackers to understand why companies give hackers codenames.
OpenAI says it slowed Astra model development over security concerns
OpenAI said this model, which is still in development, reached its "critical cybersecurity threshold," meaning it could independently identify and carry out cyberattacks against traditionally well-protected real-world systems.
After Rippling blew millions on AI in months, it built an employee ROI tool
After its own AI usage wake-up call, Rippling this week unveiled AI Spend Console, a product that tracks individual and team employee AI spending.
Wacom’s MovinkPad 11 is a fun, midpriced entry point for digital artists
The MovinkPad 11 a versatile little graphics tablet that can help make your wildest digital art dreams come true.
Security researchers scanned the Polish web and found courts, hospitals, and airports at risk of hacks
Researchers found common points of failure, like software used to organize and display web content, could have allowed hackers to run riot through government websites.
Cloudflare launches Kitesurf, a browser built for AI agents
Kitesurf is a cloud-hosted browser designed for AI agents instead of people. It uses less computing power than Chromium for common automation tasks, helping developers build browser-based AI agents more efficiently.
Computer maker Framework notifies ‘all customers’ of a data breach
Framework told "all" of its customers that hackers accessed their names, email addresses, phone numbers, and physical addresses in a data breach.
Today’s the last day to get up to $400 off your TechCrunch Disrupt 2026 ticket
Starting today, you can take an additional $100 off your founder, investor, or attendee TechCrunch Disrupt 2026 pass, which is a nice bonus on top of our current discounted pricing.
Trump administration has spent nearly $4B to cancel offshore wind farms
The Trump administration has now convinced developers to abandon 12 offshore wind leases. The latest will cost taxpayers $1.2 billion.
Host your own piece of Disrupt: Apply to run a Side Event at TechCrunch Disrupt 2026
You put together the concept — from a founder mixer, an after-hours panel, a themed party, a morning run, whatever fits your goal — and the TechCrunch team helps put it in front of the attendees already in town for Disrupt.
Chinese AI model Kimi escaped its cybersecurity testing environment, researchers say
In the Kimi test, the sandbox designed to contain the experiment was not properly configured.
Airbnb says AI is helping it ship features faster as it tests a new search function
Airbnb will debut a new AI-powered search experience with a toggle.
SpaceX’s Terafab will rely on natural gas power plants, not Tesla solar panels
The fab is intended to build chips for data centers that will be run by SpaceX and its xAI subsidiary.
The founder’s guide to TechCrunch Disrupt 2026: Everything you need to know
TechCrunch Disrupt 2026 is built around one question: How do you build an enduring company in the AI era? Our programming and speaker lineup reflect that.
New Mexico court orders Meta to pay additional $567M in child safety case
Meta's total fine has racked up to $942 million in this case.

Alternatives to vaccines: what do anti-vaccine people propose?

You missed

Spain imposes border controls against Italy as row over Ceuta migrant influx intensifies

Thai PM vows to introduce stricter gun laws after eight killed in shooting

Saudi Arabia, Turkey and Pakistan sign defence pact

Spanish police arrest 78 people in bust of ‘one of largest’ smuggling networks

Tag: clinical trial

You missed